This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
6qgh
From Proteopedia
(Difference between revisions)
m (Protected "6qgh" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Structure of human Bcl-2 in complex with ABT-263== | |
| - | + | <StructureSection load='6qgh' size='340' side='right'caption='[[6qgh]], [[Resolution|resolution]] 2.00Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[6qgh]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6QGH OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6QGH FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=1XJ:4-(4-{[2-(4-CHLOROPHENYL)-5,5-DIMETHYLCYCLOHEX-1-EN-1-YL]METHYL}PIPERAZIN-1-YL)-N-[(4-{[(2R)-4-(MORPHOLIN-4-YL)-1-(PHENYLSULFANYL)BUTAN-2-YL]AMINO}-3-[(TRIFLUOROMETHYL)SULFONYL]PHENYL)SULFONYL]BENZAMIDE'>1XJ</scene></td></tr> | |
| - | [[Category: | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[6qg8|6qg8]], [[6qgg|6qgg]]</td></tr> |
| - | [[Category: | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6qgh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6qgh OCA], [http://pdbe.org/6qgh PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6qgh RCSB], [http://www.ebi.ac.uk/pdbsum/6qgh PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6qgh ProSAT]</span></td></tr> |
| + | </table> | ||
| + | == Disease == | ||
| + | [[http://www.uniprot.org/uniprot/BCL2_HUMAN BCL2_HUMAN]] Note=A chromosomal aberration involving BCL2 has been found in chronic lymphatic leukemia. Translocation t(14;18)(q32;q21) with immunoglobulin gene regions. BCL2 mutations found in non-Hodgkin lymphomas carrying the chromosomal translocation could be attributed to the Ig somatic hypermutation mechanism resulting in nucleotide transitions. | ||
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/BCL2_HUMAN BCL2_HUMAN]] Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1).<ref>PMID:18570871</ref> | ||
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Casara, P]] | ||
[[Category: Chen, I]] | [[Category: Chen, I]] | ||
| - | [[Category: Williamson, D.S]] | ||
| - | [[Category: Smith, J]] | ||
| - | [[Category: Le Diguarher, T]] | ||
| - | [[Category: Matassova, N]] | ||
[[Category: Davidson, J]] | [[Category: Davidson, J]] | ||
| - | [[Category: Wang, Y]] | ||
| - | [[Category: Roughley, S]] | ||
| - | [[Category: Walmsley, C]] | ||
| - | [[Category: Graham, C.J]] | ||
| - | [[Category: Hubbard, R.E]] | ||
[[Category: Davis, B]] | [[Category: Davis, B]] | ||
| + | [[Category: Diguarher, T Le]] | ||
| + | [[Category: Dokurno, P]] | ||
| + | [[Category: Geneste, O]] | ||
| + | [[Category: Graham, C J]] | ||
| + | [[Category: Harris, R]] | ||
[[Category: Hickman, J]] | [[Category: Hickman, J]] | ||
| + | [[Category: Hubbard, R E]] | ||
| + | [[Category: Jordan, A M]] | ||
| + | [[Category: Kotschy, A]] | ||
| + | [[Category: Matassova, N]] | ||
| + | [[Category: Murray, J]] | ||
| + | [[Category: Pedder, C]] | ||
| + | [[Category: Ray, S]] | ||
| + | [[Category: Roughley, S]] | ||
| + | [[Category: Smith, J]] | ||
[[Category: Stark, J]] | [[Category: Stark, J]] | ||
| + | [[Category: Walmsley, C]] | ||
| + | [[Category: Wang, Y]] | ||
[[Category: Whitehead, N]] | [[Category: Whitehead, N]] | ||
| - | [[Category: | + | [[Category: Williamson, D S]] |
| - | [[Category: | + | [[Category: Abt-263]] |
| - | [[Category: | + | [[Category: Apoptosis]] |
| - | [[Category: | + | [[Category: Bcl2]] |
| - | [[Category: | + | [[Category: Drug design]] |
| - | + | ||
| - | + | ||
| - | + | ||
Revision as of 05:46, 12 June 2019
Structure of human Bcl-2 in complex with ABT-263
| |||||||||||
Categories: Large Structures | Casara, P | Chen, I | Davidson, J | Davis, B | Diguarher, T Le | Dokurno, P | Geneste, O | Graham, C J | Harris, R | Hickman, J | Hubbard, R E | Jordan, A M | Kotschy, A | Matassova, N | Murray, J | Pedder, C | Ray, S | Roughley, S | Smith, J | Stark, J | Walmsley, C | Wang, Y | Whitehead, N | Williamson, D S | Abt-263 | Apoptosis | Bcl2 | Drug design
